A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL.
The file type is application/pdf
.
Progress in the pathogenesis and related drug therapy of primary open angle glaucoma
2019
Journal of Hainan Medical University
Glaucoma is the second major cause of blindness in the world, and primary open angle glaucoma has a high incidence, complicated pathogenesis and difficult clinical diagnosis and treatment. Its main features are optic nerve damage and visual field defect, which seriously affect the quality of patients' life. The pathogenesis of primary open angle glaucoma is closely related to genetic factors, and MYOC, OPTN, WDR36 and CAV1/CAV2 genes are related to primary open angle glaucoma. The risk factors
doaj:a93427935d1240aba72a82a0e7211a80
fatcat:wjpn7tzoc5dx7djj4dqcytabwy